Sagent's Generic Cyclophosphamide Receives Approval in the U.S.
Enforcement Report - Week of May 31, 2023
Enforcement Report - Week of March 15, 2023
Sagent Pharmaceuticals, Inc. Receives FDA Warning Letter
Sagent's Generic Cyanocobalamin Receives Approval in the U.S.
CHICAGO, Nov. 19, 2021 /PRNewswire/ -- Sagent Pharmaceuticals, Inc. today announced the voluntary nationwide recall of four lots of Levetiracetam Injection, USP, to the user level. The lack of container closure integrity, found in reserve sample vials may result in a non-sterile product.
Enforcement Report - Week of March 24, 2021
A potential packaging glitch that could compromise sterility has triggered a recall at Sagent Pharmaceuticals.
Sagent Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Phenylephrine Hydrochloride Injection